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Injection of antigen into the dermis of the flank of an appropriately immu-
nized rat, guinea pig, monkey, or manresults, 24-48 h later, inthe formation of
an erythematous, indurated lesion. Similar skin testing of immunized mice
generally fails to produce such lesions (1-3). The explanation for this particular
difference between mice and men is unknown but there is reason to believe that
it may not stem from differences in immunologically competent cells. Two
observations support this view. (a) Appropriately immunized mice exhibit anti-
gen-specific delayed-type hypersensitivity (DTH)' reactions when the site of
elicitationis the foot pad(4) or the ear (5). (b) Mice exhibit most other manifesta-
tions of cell-mediated immunity, in a normal fashion, despite their failure to
produce DTH reactions in the flank skin. Thus, mice must have appropriately
reactive T cells but there may be some difficulty in delivering the cells required
for theproduction ofDTH reactions to the flank skin. In support ofthisnotion, it
has been shown thatifperitoneal exudate cells are added to the eliciting dose of
antigen placed in the flank skin the lesions that result are morphologically
indistinguishable from those of classical DTH (2). Appropriate immunization
and the inclusion ofthe specific antigen with the exudate cells are required for
the production ofthese lesions. It thus appears that sensitized T cells may react
with antigen in the flank skin of mice but that the subsequent migration of
nonimmune cells, which is required for production ofthe lesions (6-11), does not
normally ensue.
It has recently been shownthat basophils comprise a significant portion ofthe
inflammatory exudate in almost all types of DTH reactions ofguinea pigs and
man (12) and can play a functional role in these reactions (13). Since basophils
are important carriers ofvasoactive amines, we considered it possible that the
importation ofthese substances to the site ofdelayed reactions might play an
important role in the development of the lesions. If this were true, it could
explain why mice usually fail to exhibit delayed lesions in their flank skin, as
this species is markedly deficient in circulating basophils (12, 14). Production of
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lesions in the foot pads and ears might result if these areas were particularly
richin mastcells which could substitute, at least inpart, for recruitedbasophils.
Therefore, we have examined the role of vasoactive amines in the production
of DTH reactions in the foot pads of mice. Our results show that the skin ofthe
mouse's foot pad contains many more serotonin (5-hydroxytryptamine)-contain-
ing mast cells, per unit weight, than does the flank skin and that pretreatment
ofmice, with the monoamine depleting drug reserpine, blocks the elicitation of
DTH. This effect ofreserpinecanitselfbe blockedby monoamine oxidase (MAO)
inhibitors, confirming that the action of reserpine depends upon the intracellu-
lar release and catabolism of monoamines by MAO. It is known that the
monoamine serotonin is the principal mediator ofanaphylactic reactions in the
mouse (15, 16). We suggest that this substance may also play an important role
in the production ofthe lesions of DTH, perhaps by acting on the endothelial
cells ofthe postcapillary venules (17) and permitting the egress ofmacrophages
or their precursors from the blood into the sites of delayed inflammation.
Macrophages which ordinarily do not pass through postcapillary endothelium,
and thus do not recirculate, are the cells principally responsible for the swelling




Mice were 6- to 8-wk old male BDF, (C57BL/6 x DBA/2) from the Jackson Laboratories,
Bar Harbor, Maine. They were rested 1 wk in our animal facilities before use.
Immunizations
SHEEP RED BLOOD CELLS (SRBC).
￿
Groups of five-six mice were immunized, under light ether
anesthesia by intravenous injection of0.2 ml ofafreshly washed suspension ofSRBC (0.01%; about
2 x 105 cells) in saline, or by separate subcutaneous 0.05-ml injections into the four proximal limbs
of an emulsion containing (in equal parts) 10% SRBC and CFA (H37Ra, Difco Laboratories,
Detroit, Mich.), fortified with 3 mg/ml ground mycobacterium tuberculosis.
CONTACT REACTIONS.
￿
A single application of 0.1 ml of 3% oxazolone (2-phenyl-4-ethoxymethy-
lene oxazolone, Gallard, Schlesinger Corp., Carle Place, N.Y.) in ethanol was made to the freshly
shaved abdominal skin ofunanesthetized mice (5) or 0.02 ml of0.5%dinitrofluorobenzene ZDNFB,
Eastman Chemicals, Rochester, N.Y.) in a 1:4 mixture of acetone and olive oil was made on 2
consecutive days (18).
Foot PadandEar Skin Testing
FOOTPAD.
￿
Mice immunized intravenously with 0.01% SRBC were tested 4 days later [this has
been shown to be the time of optimal delayed foot pad responses produced by this mode of
immunization (19)]. Separate groups of mice immunized with SRBC in CFAwere tested at day 4
andday 10. Freshly washed 1-wk old SRBC (20% in saline) were injected (0.03 ml)into the ventral
foot pad after foot pad thickness had been measured using a micrometer (Brown & Sharpe Mfg.
Co ., No. Kingston, R. I.). Subsequent 24-h foot pad thickness was compared to the original
measurement and the percent change calculated.
EARSKIN.
￿
Contact reactions ofthe earskin were elicited by applying to each side of both ears a
drop offreshly prepared 3% oxazolone in olive oil 7 days after immunization (5) or 0.2% DNFB in
acetone-olive oil 5 days after initial immunization (18). Micrometer-measured ear thickness at 24
hs was compared to earthickness observed before contact testing, and percent change calculated.
Student's t test was used to compute statistical significance (P < 0.05).
Reactions of Passive Cutaneous Anaphylaxis (PCA) (20).
￿
Mice were contact-sensitized with
oxazolone andboosted with similar additional applications to the abdominal skin at days 7and14.
Serumharvested at day 21 was diluted twofold in saline starting at 1 :20. 0.02 ml offour separate
dilutions were injected intradermally into the shaved skin of groups of three to four Swiss mice
anesthetized with ether. 2 h later 0.2 ml saline containing Evans Blue Dye (1/4%) and 0.5 mg734
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oxazolone-human serum albumin (21) was injected intravenously. 30 min later mice were killed




The amine-depleting drug reserpine (22, 23) (Serpasil for parenteral
injection, Ciba, Summit, N.J.) was injected as asingle dose 6-12 h before testing ofthe skin or foot
pad. Reserpine has a number of advantages as an experimental tool with which to manipulate
monoamines. It hasa long duration of action on amine storage, one which outlasts thepresence of
the drug in the animal. This permits possible direct effects of reserpine to be differentiated from
the effects secondary to aminedepletions. Reversal or antagonism of reserpine's action by MAO
inhibitors permits a second check on drug specificity. Moreover, the well-characterized depletion
of amines by reserpine is intrinsically a more specific approach than would be, for example, the
use of antagonists which may have several actions, not all of which are known, and which may
block some, but not all of the amine receptors; multiple 5-HT receptors have recently been
recognized (24, 25).
MAO INHIBITORS. Pheniprazine (10 mg/kg) (Lakeside Laboratories Milwaukee, Wis.) was in-
jected intraperitoneally 30-60 minbefore injection ofradiolabeled 5-HT (see below). Pargyline HCl
(100 mg/kg) (Abbot Laboratories, No. Chicago, Ill.) was dissolved in saline and administered
intraperitoneally 30-60 min before injection of radiolabeled 5-hydroxytryptamine (5-HT) (see
below). Nialamide (100 mg/kg) (Sigma Chemical Co., St. Louis, Mo.) was freshly solublized in 3 M
HCL andthe pH was adjusted to 5.0 by the addition of 1 N NaOH. Water was added to bring the
concentration to 10 mg/ml and the diluted drug wasadministered a few minutes before reserpine
and every 6 h thereafter to block the MAO catabolism of released monoamines.
BURIMAMIDE.
￿
Burimamide (500 )Amol/kg), a blocker of Histamine-2 (112) receptors (26) (gift
from Smith Kline & French Labs, Welwyn Garden City, Herts, England) was administered
subcutaneously 1 day before foot pad testing.
6-HYDROXYDOPAMINE HYDROBROMIDE. 6-Hydroxydopamine (100 mg/kg) (Sigma Chemical Co.,
St. Louis, Mo.), which produces achemical sympathectomy (27), was dissolved in saline containing
ascorbic acid (1 mg/ml) and injected subcutaneously twice, 48 and24 h before testing the treated
mice.
Determination of the Uptake of5-HT
SCINTILLATION COUNTING.
￿
(a) In the skin: Six mice were pretreated at 48 and 24 h with 6-
hydroxydopamine and with the MAO inhibitor pheniprazine. 30 min after the injection of pheni-
prazine the animals received 0.1 mCi of tritiated 5-HT ([311]5-HT in 0.1 ml saline; serotonin
binoxalate, NewEnglandNuclear Corp. Boston, Mass., 1.33 Ci/mmol) intravenously. 2 hlater the
mice were killed by cervical dislocation andskin wasremoved from the feet, flanks, and ears. Care
wastaken to avoid including cartilage with the samples of earskin. Tissues were quickly weighed
and homogenized in 5.0 ml of 70% ethanol. The resulting suspensions of tissue were allowed to
stand overnight at 4°C. After centrifugation at 12,000 g for 20 min, aliquots were removed for
chromatographic analysis and liquid scintillation counting. This procedure has been shown to
extract better than 95% of the radioactive 5-HT from tissues (28). Thin-layer chromatography done
with butanol:acetic acid:water (12 :3:5) or isopropanol:ammonia :water (10:1 :1) on cellulose (East-
man Chemicals) revealed that radioactivity measured in the ethanolic extracts was taken as an
assay of the amount of [311]5-HT in the tissue and was expressed as dpm/g. Sampleswere dissolved
in 15 ml of"Aquasol" (New EnglandNuclearCorp.) for liquid scintillation counting andcorrected
for quench by external standardization.
(b) In tumors: Mice carrying a mast cell tumor (P-815) were injected intraperitoneally with 100
mg/kg of pargyline to inhibit MAO. 1 h later each mouse was injected intraperitoneally with 0.1
mCi of [311]5-HT. Another two mice carrying the mast cell tumor were injected with 5 mg/kg of
reserpine 4 h before injection of [311]5-HT. One of these animals was given pargyline as above and
theother received no other drugs before injection of the isotope. 2 h after the injection of [311]5-HT
all mice were killed, their abdomens opened and washed with 2 .0 ml of iced Krebs solution, and
the tumor cells collected.
After collection in Krebs solution, the cells were pelleted by centrifugation at 1,200g for 10 min
in a refrigerated centrifuge. The supernate was discarded, the cells were drained, and the pellets
were weighed. 5 ml of 70% ethanol was then added to the cells. The cells were homogenized,R. K. GERSHON, P. W. ASKENASE, AND M. D. GERSHON
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allowed to stand overnight, centrifuged again as described above, and aliquots of the supernate
were taken for liquid scintillation counting and chromatographic analysis.
RADIOAUTOGRAPHY.
￿
Experiments were designed to determine if theassumption that all ofthe
tritiated 5-HT in theskin waslocalized to mast cells wasvalid. This wasdone by radioautography.
Methods were the same as those described by Gershon and Ross (29, 30).
Five mice were injected intravenously with 5.0 mCi of tritiated 5-HT creatinine sulfate
(Amersham/Searle Corp., Arlington Heights, Ill. ; spec act 5-18 Ci/mmol). Injection volume was
0.1 ml. Pheniprazine was given to inhibit MAO 60 minbefore injection ofthe isotope. Segments of
skin were removed after 2 h and fixed in iced 6.25% gluteraldehyde made hypertonic by the
addition of9% sucrose and buffered to pH 7.4 by 0.1 Mphosphate buffer. Under these conditions of
fixation, movement of [3H]5-HT is abruptly halted (27, 29). [3H15-HT is preserved in situ but its
metabolites are not. After fixation for 2 h in gluteraldehyde, tissues were washed briefly in the
sucrose-containing buffer solution and were postfixed for 1 hin 1% OSO4. TheOSO. was buffered to
pH 7 .4 with 0.1 M phosphate buffer containing 9% sucrose . The tissues were then rapidly
dehydrated andembedded in epoxy resin (Epon 812) . Sections were cutat 0.5 Wm, placed on glass
slides, and coated with Ilford L4 emulsion (diluted 1 :1) by dipping. The emulsion-coated slides
were exposed for 1 wk in a dry, light-tight box under an atmosphere of 100% CO2. After
photographic development and processing, slides were stained with toluidine blue for light
microscopic examination. None ofthe processing ofthefixed tissues extracts significant quantities
of radioactive material (29-31).
Histochemical Demonstration of5-HT.
￿
Tissue was examined histochemically for the presence
of 5-HT by theformaldehyde-induced fluorescence technique of Falck andHillarp (see 32 for refs.).
Treatment of the frozen-dried tissues with paraformaldehyde was modified according to the
procedure of Fuxe and Jonsson (33). Briefly, small pieces of tissues were quenched in melting
Freon 22 that hadpreviously been cooled with liquid nitrogen. Tissues were freeze-dried overnight
in a Pearse-Edwards freeze drier, and then exposed at 80°C to formaldehyde gas generated first
from paraformaldehyde equilibrated at 70% and then at 90% relative humidity. Tissues were
embedded in hydroxybutyl methacrylate, sectioned at 3 Wm, andmounted on slides in nonfluores-
cent immersion oil under quartz cover slips for fluorescence microscopy . The microscope was fitted
with a vertical illuminator (Leitz Ploem system, E. Leitz, Inc., Rockleigh, N.J.). Identification of
the fluorophore as that of5-HT wasdone by microspectrofluorophotometry (Leitz-Schoeffel micros-
pectrofluorophotometer). Activation maxima were at 385 and420 nm andthe emission maximum
wasat 520 nm. Controls included tissues heated as above at 80°C butnotexposed to paraformalde-
hyde. Hairs fluoresced in the absence of formaldehyde treatment and was therefore due to
autofluorescence and notto the presence of a monoamine.
Histochemical Demonstration ofHistamine.
￿
Tissue also was examined histochemically for the
presence of histamine by the o-phalaldehyde-induced fluorescence technique of Ehinger and
Thunberg (34) as modified by Cross et al. (35). Freeze-dried tissue was embedded in paraffin,
sectioned at 5 jLm, deparaffinized with xylene, exposed to o-phalaldehyde vapor at 100°C, and
subsequently humidified. Sections were mounted in Entellan (Merck Chemical Div., Merck and
Co., Inc., Rahway, N.J.) and examined by fluorescent microscopy using a vertical illumination
and a TK 400 dichroic beam splitting mirror and a K 430 suppression filter.
Results
Distribution of Mast Cells at Various Skin Sites in the Mouse.
￿
We studied
mast cell distribution by several techniques : (a) After chemical sympathectomy
for the prevention of [3H]5-HT uptake by adrenergic nerves, we measured the
uptake of [3H]5-HT in various regions of the skin. The results (Table I) indicate
that the concentration of mast cells, as determined by their ability to take up
radioactive 5-HT, is in the order offoot greater than ear greater than flank.
The quantitative results obtained by scintillation counting were checked by
radioautography to determine where in the skin the 5-HT had localized. More
[3H]5-HT was given (50 times as much) to be certain that small amounts bound
in unexpected locations would not be overlooked. The only labeled structures736
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TABLE I
Localization of Injected [3H]5-HT at Various Skin Sites
P values : ear vs . foot = <0.02; foot vs . flank = <0.01; ear vs . flank =
<0.05 .
FIG . 1 .
￿
Radioautograph of the subcutaneous tissue of a mouse which was injected with
radioactive serotonin ([3H]5-HT) . Only certain cells localized [3H]5-HT and were heavily
labeled, while nearby cells took up no label . Staining with toluidine blue showed that the
cytoplasm of the heavily labeled cells containednumerous large metachromatatic granules .
Variation of the plane offocus at lightly labeled areas of these cells revealed that the grain
pattern corresponded to the shape and position of the granules (x 950) .
that we could find in any ofthe slides of skin were mast cells (Fig . 1) . These cells
could be readily identified by their metachromasia in the toluidine blue-stained
sections under the layer of photographic emulsion . The cells were very heavily
labeled . No evidence of uptake of5-HTby perivascular sympathetic nerves could
be found . Ifanimals were treated with reserpine (5 mg/kg) 1 day before injection
of [3H15-HT, no labeled mast cells were found . These observations support the
Region of skin dpm/g ± SE
Foot 173,000 ± 42,000
Flank 15,400 ± 1,500
Ear 47,200 ± 14,000R. K. GERSHON, P. W. ASKENASE, AND M. D. GERSHON
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view that mast cells account for the uptake of labeled 5-HT by the skin.
Therefore, the amount oftritiated 5-HT found in the skin probably is a function
of the number of activity of the mast cells in the area.
(b) Independent confirmation ofthe quantitative data derived from studies of
the uptake of [3H]5-HT, suggesting that mast cells were most numerous in the
skin ofthe foot, was sought . Mast cells ofmice and rats are known to contain 5-
HT and histamine (see 14). Therefore, 5-HT and histamine was demonstrated in
sections of the skin histochemically in order to visualize mast cells and to
estimate their numbers. By means offormaldehyde (5-HT) and o-phalaldehyde
(histamine)-induced histofluorescence, many brightly fluorescent mast cells
could be seen in sections ofthe skin ofthe foot, especially on the dorsal surface
clustered around autofluorescent hair follicles (Fig. 2). Far fewer fluorescent
mast, cells were found in sections of flank skin (Fig. 3), while ear skin had
intermediate numbers. These results confirm those above; that mast cells inthe
skin which contain 5-HT are far more numerous in the skin of the feet and
somewhat more numerous in the skin ofthe ears than of the flank, and that
histamine-containing mast cells have the same distribution. Mast cells identi-
fied by numerous cytoplasmic metachromatic granules in paraffin sections
viewed with an ordinary light microscope after Helly's fixation and Giemsa
staining (36) were similarly distributed.
The Effect ofReserpine on the Uptake of5-HT.
￿
Radioautographic observa-
tions indicated that pretreatment of mice with reserpine totally ablated the
capacity of the mast cells to take up and/or store 5-HT. We also studied the
ability ofreserpine to block the uptake of [3H]5-HT by P815 mastocytoma cells.
As a specificity control for the uptake ofthe 5-HT by the mastocytoma cells, we
used a different mouse tumor, sarcoma I. The results ofthis experiment (Table
II) show that the mast cell tumor took up more 5-HT than did sarcoma I cells.
Reserpine antagonized the ability ofthe tumor cells to accumulate 5-HT andthis
antagonism was partially overcome by the administration ofthe MAO inhibitor
pargyline.
Effect of Reserpine Pretreatment on the Ability of Mice to Make a DTH
Response to SRBC. Mice were immunizedintravenously with 0.2 ml ofa0.01%
suspension ofSRBC. Their ability to mount a DTH response was tested 4 days
later by injecting 0.03 cc of SRBC into the foot and measuring the increase in
foot pad thickness 24 li later. Some of the mice were treated with reserpine
alone, some with reserpine plus the MAO inhibitor nialamide, some with 5-
hydroxydopamine as a control for the effects ofreserpine on norepinephrine (27),
and some withburimamide, a blockerofhistamine-2 (H2) receptors (26) [antihis-
tamineswhich work on H, receptors are known notto affect reactions ofdelayed
hypersensitivity (37) and in any case the mouse is extraordinarily resistant to
histamine (see 16)]. The results ofthis experiment (Table III) show that reser-
pine treatment abrogatedthe DTH response occurring 24 h after challenge with
antigen, that the MAO inhibitor nialamide partially reversed this suppression,
and that the depletion of norepinephrine alone and H2 blocking were without
effect. We subsequently found that delaying the injection of an MAO inhibitor
until 6 h after administration ofreserpine fails to reverse the effect ofreserpine
on DTH reactions but does reverse the central nervous system effects.FIGS . 2 and 3 .
￿
Formaldehyde induced fluorescence of serotonin (5-HT) in the skin ofmice .
5-HT-containing cells were quite numerous in the dorsal foot skin (Fig . 2), and were
localized to the upper dermis where mast cells were most numerous as judged by light
microscopy . The cells at the lower right demonstrate that 5-HT was localized to the
cytoplasm (x 100) . Fluorescent cells were noted only occasionally in the flank skin (Fig. 3) .
[(o-phalaldehyde-induced fluorescent cells (histamine-containing) were similarly distrib-
uted).]




Uptake of [3H]5-HT by DifferentDrug Treated or Control Tumor
Cells
TABLE III
Reserpine Inhibition of DTH (0.01% Intravenous SRBC
Reserpine Inhibition of DTH (SRBC + CFA Immunization)
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We tested the possibility that the low dose SRBC immunization schedule we
used wasnot truly representative of a DTH response . To do this, we immunized
mice with SRBC in CFA and tested the abilityofreserpine to block the delayed-
hypersensitivity response in the footpad 4 and 10 days after immunization. The
results (Table IV) show that reserpine could block the delayed response to this
form of immunization as well as it could to the low dose immunization.
Effect of Reserpine on Contact Reactions.
￿
We also tested the ability of
reserpine to inhibit reactions of contacthypersensitivity occurring on the mouse
ear. The results (Table V) show that reserpine was also able to inhibit these
forms of DTH, although the inhibition was not as complete as in the SRBC
system.
Effect ofReserpine on Passive Cutaneous Anaphylaxis.
￿
Our results indicate
that reserpine can significantly suppress several types of DTH reactions and
that MAO inhibition can partially prevent this suppression in at least oneform
Immunization)
Drug 24 h foot pad thickness
% increase ± SE
None 57 ± 5
Reserpine 4 ± 2
Reserpine + nialamide 31 ± 6
6-Hydroxy-dopamine 64 ± 6
Burimamide 64 ± 7
Cells (and drug treatment) dpm/g (mean of cell
pools)
Sarcoma I (none) 238,000
Mastocytoma cells (none) 1,110,000
Mastocytoma cells (reserpine) 33,000
Mastocytoma cells (pargyline + reserpine) 346,000740
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Drug
TABLE V
Reserpine Inhibition ofDTH (Contact Hypersensitivity)
TABLE VI
Reserpine Inhibition of PCA Reactions
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￿
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￿
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Reserpine
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of DTH. This latter point was of particular interest since reserpine is known to
act by causing stored amines to leak from the granules of mast cells into the
cytosol, where they are inactivated by MAO (38). Since inhibition of MAO after
reserpine would lead to the accumulation of free amine in the cytosol of mast
cells, this suggested that some form of nongranule release of amines might be
occurring. We therefore tested whether reserpine could inhibit PCA reactions
whichare known to be dependent upon exocytosis of mast cells granules (39) and
to see whether nialamide could reverse that form of inhibition. The results of
three pooled experiments (Table VI) show that reserpine significantly inhibited
PCA reactions, but in contrast to the DTH reactions, nialamide was now unable
to reverse this inhibition.
Effect of Adrenalectomy on the Ability of Reserpine to Block Reactions of
DelayedHypersensitivity. Although ourresults show that reserpine treatment
affects the ability of mast cell granules to bind andstore 5-HT, we considered the
possibility that this was not causativelyrelatedto its abilityto block reactions of
DTH but that there might be an indirect action. We had ruled out effects
secondary to reserpines tranquilizing action by the differential protection af-
forded on behavioral effects and DTH by delayed treatment with MAO inhibi-
tors. Another indirect action could come from stress and the subsequent release
of corticosterone from the adrenals. We therefore tested the ability of reserpine
to inhibit DTH reactions in adrenalectomized mice. The results of this experi-
ment (Table VII) show that adrenalectomy was without significant effect on the
DTH in either untreated or reserpine-treated mice. Therefore, nonspecific stress
was not a significant factor in our results.
Effect of Adoptive Transfer of Immune Spleen Cells from Reserpine-Treated
Immunization Reserpine 24 h ear
thickness
% increase ± SE
Oxazolone - 90 ± 9
Oxazolone + 38 ± 10
DNFB - 37 ± 6




Effect of Reserpine on DTH in Adrenalectomized Mice (0.01 %
SRBC Immunization)
TABLE VIII
DTH Transfer into and out ofReserpine-Treated Mice (Donors
immunized with 0 .01 % SRBC)
Mice . We performed a more direct test for secondary effects of reserpine
treatment by doing adoptive transfer experiments. We immunized mice with
SRBC and treated some ofthem on day 4 with reserpine. 8 h after injection of
reserpine, we harvested the spleens and transferred the resultant cell suspen-
sion (one spleen : two recipients) to normal nonimmune syngeneic mice, some of
which had been pretreated with reserpine at the same time as the donor mice.
The results (Table VIII) show thattreatment ofdonors withreserpine abrogated
their ability to mount a DTH response (line 4). However, spleen cells of the
reserpine-treated donors, who themselves couldnot make a DTH response, were
able to transfer DTH to normal recipients (line 3), as well as spleen cells from
donors who had not been treated with reserpine (line 1). If however, the
recipients had been treated with reserpine, the transfer ofimmune spleen cells
failed to convey the ability to mount a DTH response to the recipient (line 2).
Therefore, reserpine acts on cells ofthe host, not on the immunocompetent cells
of the donor.
Discussion
We would like to set forth some previously made observations and those
elucidated in the presentstudy, and from themput forth a hypothesis to explain
certain elements ofdelayed hypersensitivity reactions and their relationship to
other immunological phenomena. Pertinent observations made in previous
studies include the following: (a) mice are relativelydeficient, compared to other
animals, in their ability to make DTH reactions inthe flank skin (1-3); (b) they
nevertheless make excellent DTH reactions when the eliciting antigenisplaced
Reserpine treatment 24 h foot pad thickness in recipients
% increase ± SE
(1) None 44 ± 4
(2) Recipient 1 ± 3
(3) Donor 40 ± 5
(4) "Donor" 5 ± 2 (reaction in donor)
Adrenalex Reserpine 24 h foot pad thickness
% increase ± SE
_ _ 54 ± 7
- + -3±1
+ - 62 ± 5
+ + 2 ± 1.5742
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in the foot pad (3, 4) or on the ear (3, 5); (c) mice are relatively deficient in
basophils, circulating cells which carry vasoactive amines (12, 14), and these
cells are often found inthe cellular exudate in DTH reactions ofother mammals
(12); (d) vasoactive amines allow intravascular contents to pass into the tissue
by causingthe endothelial cells ofpostcapillaryvenules to contract and separate
(17); (e) the predominant recirculating lymphocyte found in the mouse thoracic
duct is a T cell (40), indicating that these cells are especially equipped to leave
the blood and enter the lymph; (f) T cells play an important role in the
recruitment and/or entrapment ofcells from the circulation to lymphoid tissues
draining sites of exogenously administered antigen (41).
Observations made in the present study include the following: (a) mast cells
which contain vasoactive amines are particularly numerous at skin sites in the
mouse where DTH reactions are most easily elicited; (b) vasoactive amine
depletion by reserpine severely inhibits various DTH reactions; (c) the tech-
niques usedfor depletionofvasoactive amines do not alter the abilityofT cellsof
treated mice to adoptively transfer DTH reactions to normal recipients. Thus,
the site ofaction ofvasoactive amine depletion is not atthe level ofthe effector T
cell; (d) pharmacological treatments which cause depletion ofvasoactive amines
from mast cells granules, but which favor accumulation of free amine in the
cystosol, (reserpine plus MAO inhibitors) eliminate reactions of passive cuta-
neous anaphylaxis but not those of delayed hypersensitivity.
To account for these observations, we propose that T cells are especially
equipped to traverse the endothelium of postcapillary venules, which they
continually do. Ifthey are appropriately immune and meet the specific antigen
outside of the circulation, they release a factor that causes nearby mast cells
and/or basophils to release their vasoactive amines. If basophils are absent,
mast cells acquire added importance. The released amines cause the endothelial
cells of the postcapillary venule to separate, allowing the rapid egress from the
blood ofcells which do not normally recirculate. Nonrecirculating cells coming
from the bone marrow are the predominant cell type that causes the swelling
and induration of a delayed hypersensitivity reaction (6-11) . There probably is
an additional element of a T-cell-released chemotactic substance or substances
which attract the appropriate cells to the site (42). However, the release ofthese
chemotactic substances is insufficient initselfto permit the secondarily arriving
cells to enter the reaction site, unless the walls ofthe postcapillaryvenuleshave
been acted upon by vasoactive amines.
This T cell-to mast cell-to postcapillary venule reaction is also probably very
important in the general regulation of lymphocyte traffic. [We have evidence
that depletion of5-HT from the mouse abrogates the antigen-driven trapping of
lymphocytes in the lymph nodes but not in the spleen (Gershon and Kondo,
unpublished observations).] This may be why workers studying the mode of
entrance oflymphocytes into nonantigen-stimulated lymph nodes find that cells
go through, rather than between, endothelial cells (43). Those who study the
mode ofentrance in lymphoid tissue ofthe gut where there is constantantigenic
stimulation have found that the cells go between the endothelial cells of the
postcapillary venule (44). There may be a continuing antigen-to T cell-to mast
cell reaction going on in lymphoid tissue draining the gut, which accounts for
the different mode of circulation.R. K . GERSHON, P. W. ASKENASE, AND M . D. GERSHON
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Although our results do not bear directly on the mechanism by which T cells
cause mast cells to release their vasoactive amines, they do suggest that the
mechanism is different than that ofPCA reactions, which involve exocytosis of
amine storage granules (39). MAO inhibition should not affect any response
which is mediated solely by granule release because oxidative deamination
takes place in the cell cytosol rather than in the granule (22, 23). Reserpine
causes 5-HT to leak out ofgranules into the cytosol where inactivation by MAO
takes place (22, 23, 38, 45). Thus, MAO inhibition in theory should only protect
reserpine-inhibited reactions in which the cytosol as well as the granules is
released. Since MAO inhibition partly protected the delayed response of mice
treated with reserpine and failed to protect the PCA response, it seems probable
that mast cell cytosol is released in delayed reactions. Cytosol release would
occur ifthe mast cell was killed or damaged by the T cell. T cellsofappropriately
immunized mice are known to migrate to the skin and to release cytotoxic
factors in the presence ofspecific antigen (2, 46). These released factors are toxic
for macrophages and may be related to the lymphokine called lymphotoxin (47).
If lymphotoxin was toxic for mast cells it could be the important link between
the T cell and the firing ofthe mast cell. A number ofpoints raised in the above
hypothesis are easily testable. Some of them have already been confirmed and
others we are in the process oftesting.
Several remarks of clarification are in order. Although all the evidence we
have presented suggests that 5-HT is the main vasoactive amine involved in the
mediation of the reactions of DTH in the mouse [as it is in anaphylactic
reactions (16)], we wish to stress that participation by other amines or factors
has not been ruled out. There is ample evidence to indicate that different
vasoactive amines can interact with one another in the production of vascular
alterations (48). In addition, the role of 5-HT carrying platelets (49) in these
reactions mustbe considered. Clearly, a great deal more work is requiredbefore
the chemical basis for our observations can be soundly and thoroughly eluci-
dated. The present report serves simply to implicate the importance ofvasoac-
tive amine release in DTH. This fact has heretofore not been fully appreciated,
although the early work ofVoisin was highly suggestive in that it showed that
vascular permeability changes occurred during the evolution of DTH reactions
(50). Perhaps one reason the establishment ofthe role of vasoactive amines in
DTH has been delayed is that the amines and the interactions between them
and their various cell receptors are so complex. For example, the nature of
histamine (26) and serotonin (24, 25) receptor subtypes has only been recently
recognized. The mouse is probably an exceptional model for these studies since
histamine mediation ofvascular reactions in this species is so much less impor-
tant than in others (16), allowing us to manipulate the response by affecting the
storage of5-HT. Obviously, we must try toduplicate our results in other species
but, from ourpreliminary attempts to do so in the guinea pig, it seems that this
will be a more formidable task than it was in the mouse. We should also point
out that there have been a number of reports on the effect of reserpine on the
immune response (see 51). These previous studies, however, all used multiple
injections ofreserpine, which led to cachexia and stress; therefore it is difficult
to relate them to the findings we have made.
Finally, we would like to comment on what relationship our findings may744
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have to other areas of cellular immunology such as tumor rejection. It has been
shown that some tumors can elicit a very strong cell-mediated immune response
against themselves and yet continue to grow progressively in the face of this
immune response until death of the host; a phenomenon referred to as concomi-
tant immunity (52) . Although the primary tumor is not rejected, subcutaneous
or intravenous grafts of isolated tumor cells fail to take in the animal with the
progressively growing tumor. In addition, the concomitant immunity is able to
prevent viable circulating tumor cells in the tumor-bearing host from forming
metastatic deposits. Although quantitative factors are certainly involved, it has
been shown that, over and above these, the tumor acquires resistance to the
hosts immune response when it becomes stromatized (53). We suggest that a
possible mechanism accountingfor the phenomenon of concomitant immunity is
that tumors may lack (a) mast cells, or (b) postcapillary venules and thus may
be isolated to some degree from the immune killer cells they have engendered in
the host in which they are growing. A parallel situation has been reported in
experiments on allergic encephalomyelitis (54, 55) .
The work we have presented highlights an important, under-investigated
area ofimmunology: delivery of cells to sites of reaction. The finding that tumor-
bearing hosts contain lymphocytes which are able to kill tumor cells in vitro but
which have not been demonstrated to have in vivo effects, indicates that the
problem of delivery may be of broader importance in health care then has
heretofore been generally realized .
Summary
The skin sites of the mouse where delayed-type hypersensitivity (DTH) reac-
tions are most easily elicited (foot pads and ears) are particularly rich in 5-
hydroxytryptamine (5-HT)-containing mast cells. Since mice are deficient in
circulating basophils, which play a role in at least some DTH reactions, we
investigated the possibility that the mast cells were playing an important role in
the evolution of the skin reactions of DTH in mice . We found that reserpine, a
drug which depletes mast cells of 5-HT, abolished the ability of the mouse to
make DTH reactions in the skin. The suppressive effect of reserpine could be
partially blocked by monoamine oxidase inhibitors which prevent the degrada-
tion of 5-HT in the cytosol of the mast cell . Spleen cells of immune, reserpine-
treated mice transferred DTH reactions to nonimmune mice normally, indicat-
ing that the reserpine treatment did not affect immune T cells. DTH reactions
could not be transferred into reserpine-treated mice.
We suggest that T cells are continually emigrating from the blood, through
postcapillary venule endothelium, by a mechanism which does not depend on
vasoactive amines. If they are appropriately immune and meet the homologous
antigen in the tissue, they induce mast cells to release vasoactive amines which
cause postcapillary venule endothelial cells to separate, allowing the egress
from the blood of cells which ordinarily do not recirculate . The secondarily
arriving vasoactive amine-dependent cells are responsible for the micro- and
macroscopic lesions of DTH reactions. Chemotactic factors may also be involved
in bringing cells to the DTH reaction sites but we propose that T-cell regulation
of vasoactive amine-containing cells allows the effector cells to pass through the
endothelial gates after they are called.R. K. GERSHON, P. W. ASKENASE, AND M. D. GERSHON
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